WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Ent...(ogy companies for its high quality drug ...)
| HOME >> BIOLOGY >> TECHNOLOGY |
ogy companies for its high quality drug R&D outsourcing services. In August 2007, WuXi PharmaTech went public as the first NYSE listed company in China's rapidly growing pharmaceutical R&D outsourcing industry.
"I am very honored to be included on this list and to see WuXi PharmaTech's success recognized by Entrepreneur," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Our modest success is attributable to the support and trust from our customers and our unwavering focus on quality. China's advantageous business environment and rapid economic growth have created many opportunities for entrepreneurs. I hope more people can realize their dreams and create value for their customers, employees and the society."
About Entrepreneur China Edition
Entrepreneur China edition is a monthly business magazine issued by International Data Group (IDG) and Zero2IPO Group. As China's sole licensed partner of Entrepreneur Media Inc., Entrepreneur China edition provides networks and guidelines to Chinese entrepreneurs by offering Chinese business owners with inspiration and information on marketing, management, technology, the latest trends and strategies.
About WuXi PharmaTech
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading
China-based pharmaceutical and biotechnology R&D outsourcing company. As a
research- driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical and biotechnology companies with a broad and integrated
portfolio of laboratory and research manufacturing services throughout the
drug discovery and development process. WuXi PharmaTech's services are
designed to assist its global partners in shortening the cycle and lowering
the cost of drug discovery and development by providing cost-effective and
efficient outsourcing solutions that save its customers both time and
money. Its operations are grouped into two segments: laboratory services,
consisting of discovery chemistry,
'/>"/>
| SOURCE WuXi PharmaTech Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
2. WuXi PharmaTech Announces Second Quarter 2007 Results
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Aflac Honored with Corporate Citizenship Award
11. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |